Cargando…
Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there?
Introduction: Globally, there is a considerable burden of HCV and HIV infections among people who inject drugs (PWID) and transmission of both infections continues. Needle and syringe programme (NSP) and opioid substitution therapy (OST) coverage remains low, despite evidence demonstrating their pre...
Autores principales: | Grebely, Jason, Dore, Gregory J., Morin, Sébastien, Rockstroh, Jürgen K., Klein, Marina B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577699/ https://www.ncbi.nlm.nih.gov/pubmed/28782335 http://dx.doi.org/10.7448/IAS.20.1.22146 |
Ejemplares similares
-
Prison‐based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling study
por: Stone, Jack, et al.
Publicado: (2022) -
Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?
por: Müllhaupt, Beat, et al.
Publicado: (2018) -
It may take many villages, but progress can be made toward HCV elimination among people who inject drugs
por: Page, Kimberly
Publicado: (2023) -
HCV elimination among people who inject drugs. Modelling pre- and post–WHO elimination era
por: Gountas, Ilias, et al.
Publicado: (2018) -
Chemical genomics: what will it take and who gets to play?
por: MacBeath, Gavin
Publicado: (2001)